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more directly affect activities. As one step in developing
an OAB-specific QoL instrument, we conducted a popu-
lation-based study to determine the reliability of report-
ing of coping strategies and other aspects of QoL thought
to be OAB-related. METHODS: A US population sample
of 231 adults completed an interview twice, on average,
two weeks apart. Detailed questions were asked about
OAB symptoms, coping strategies, and the psychological/
physical impact of symptoms in the past 4 weeks. RE-
SULTS: The most common coping strategies were re-
stricting fluid intake (day or night) and defensive voiding.
Relatively high kappas (i.e., 0.60) were observed for
‘concerned about drinking more fluid’, ‘limiting travel’,
‘defensive voiding in a new place’, and ‘drink less fluid at
night’. Reports on the level of distress caused by cop-
ing and on the use of protective pads were highly reliable
(r  0.81; r  0.82). The most common terms for report-
ing feelings about bladder control included ‘annoyed’,
‘concerned’, and ‘bothered’, all of which were reported
with high reliability (kappa  0.60–0.71); few individu-
als used distressing or ‘ashamed’. Interference with activ-
ities was associated with ability to travel, attending social
events and exercising (kappa0.60). CONCLUSIONS:
Using a 4-week recall period and with a 2-week interval
between interviews, we found that individuals are highly
reliable in reporting on coping strategies, psychological
impact, and the impact of bladder control on activities.
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Overactive bladder (OAB) is a chronic but treatable
problem among older adults. Epidemiological studies
suggest that OAB is widespread, largely untreated, and
healthcare systems may be incurring substantial costs.
OBJECTIVES: We examined older adults who received
medical services for OAB, the range of OAB services,
their cost to Medicare, and the dynamics of OAB treat-
ment. METHODS: Medicare claims covering 1994 and
1995 for a 5% sample of beneficiaries was analyzed to
derive treatment rates and profile OAB services and
costs. A Markov model was estimated to examine OAB
service utilization over time, and to compare costs among
patients receiving OAB services. RESULTS: Annually,
1.4 to 2.9% of Medicare elders receive medical services
for OAB; however, this group accounts for only 4 to 5%
of elderly with symptoms indicative of OAB. Average an-
nual Medicare costs for OAB services in 1995 was $298.
Although most patients were treated by physicians at
modest expense, most Medicare spending was for a small
percentage of patients who incurred expensive OAB care.
These high cost patients either underwent surgery for
OAB, or received OAB home health, or OAB care in a
skilled nursing facility. Annual costs of OAB services var-
ied with treatment setting. Patients treated in the physi-
cian’s office showed the lowest annual treatment cost.
CONCLUSIONS: Although OAB is widespread, most el-
ders avoid medical treatment. Yet, treatment in physician
offices is not expensive, particularly compared to the
costs of complications when OAB is left untreated. These
findings are important in view of the aging population
and the prevalence of OAB.
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OBJECTIVE: This study was conducted to determine the
influence of pharmaceutical care services on renal trans-
plant patients’ systolic and diastolic blood pressures.
METHODS: Renal transplant patients at the Medical
College of Georgia Renal Transplant Clinic were pro-
spectively randomized into an intervention or a control
group. Patients in the intervention group received phar-
maceutical care services at least once monthly which in-
cluded ongoing medication reviews, with emphasis on
preventing or resolving medication-related problems and
providing pharmacotherapy recommendations. Patients
in the control group received routine clinic services but
had no clinical pharmacist interaction. At each clinic
visit, all patients underwent a physical exam which in-
cluded blood pressure measurements. Analysis to detect
differences in baseline and quarterly systolic and diastolic
blood pressures between the groups was performed. RE-
SULTS: There were no differences in baseline systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
between the groups. Patients in the intervention group
(n  28) had a mean SBP/DBP change of 9 mm Hg/2
mm Hg, 13 mm Hg/8 mm Hg, 13 mm Hg/10 mm
Hg, and 6 mm Hg/6 mm Hg for the first through the
fourth quarters of the study, respectively. Patients in the
control group (n  23) had a mean SBP/DBP change of
2 mm Hg/1 mm Hg, 10 mm Hg/3 mm Hg, 11
mm Hg/1 mm Hg, and 12 mm Hg/5 mm Hg for the
first through the fourth quarters of the study, respec-
tively. Significant differences in change scores from base-
line for SBP and DBP between the intervention and con-
trol groups were observed at the second, third, and
fourth quarters of the study (P  0.01). CONCLUSION:
Patients who received a hypertension management pro-
gram which included pharmaceutical care services had
greater reductions in blood pressure than patients who
did not receive these services.
